ADIL
Adial Pharmaceuticals Inc (ADIL)
$95
About Adial Pharmaceuticals Inc (ADIL)
Adial Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment or prevention of addiction and related disorders. It offers the AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson and William B. Stilley, III in November 2010 and is headquartered in Glen Allen, VA.
Details
Daily high
$0.96
Daily low
$0.94
Price at open
$0.96
52 Week High
$4.17
52 Week Low
$0.76
Market cap
6.1M
Dividend yield
0.00%
Volume
57,113
Avg. volume
93,317
P/E ratio
-.19
Adial Pharmaceuticals Inc News
Details
Daily high
$0.96
Daily low
$0.94
Price at open
$0.96
52 Week High
$4.17
52 Week Low
$0.76
Market cap
6.1M
Dividend yield
0.00%
Volume
57,113
Avg. volume
93,317
P/E ratio
-.19